Uptake of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) in Uganda: a national survey

被引:4
|
作者
Ameyaw, Edward Kwabena [1 ,2 ]
机构
[1] Lingnan Univ, Inst Policy Studies, Tuen Mun, Hong Kong, Peoples R China
[2] Lingnan Univ, Sch Grad Studies, Tuen Mun, Hong Kong, Peoples R China
关键词
Malaria; Pregnancy; Public health; Maternal health; Uganda; INTERVENTIONS; HEALTH;
D O I
10.1186/s12936-022-04299-z
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background In spite of the missed opportunities of sulfadoxine-pyrimethamine (IPTp-SP) in Uganda, scanty literature exist on malaria in pregnancy. To date, empirical national study utilizing the 2018-19 Uganda Malaria Indicator Survey to explore predictors of attaining three or more doses of IPTp-SP in the country is non-existent. This study investigated the factors affecting uptake of three or more IPTp-SP doses as recommended by the World Health Organization. Methods Data from the 2018-2019 Uganda Malaria Indicator Survey (2018-19 UMIS) was analysed. Adequate uptake of intermittent preventive therapy with IPTp-SP was the dependent variable for this study. Weighted frequencies and percentages were used to present the proportion of women who had adequate IPTp-SP uptake or otherwise with respect to the independent variables. A three-level multilevel logistic regression was fitted. The Bayesian Deviance Information Criterion (DIC) was used in determining the goodness of fit of all the models. Results Less than half of the surveyed women had three or more IPTp-SP doses during their last pregnancies (45.3%). Women aged 15-19 had less odds of receiving at least three IPTp-SP doses compared to those aged 45-49 [aOR = 0.42, Crl = 0.33-0.98]. Poor women [aOR = 0.80, Crl = 0.78-0.91] were less likely to have three or more doses of IPTp-SP relative to rich women. Most disadvantaged regions were aligned with less likelihood of three or more IPTp-SP uptake [aOR = 0.59, CI = 0.48-0.78] compared to least disadvantaged regions. The variation in uptake of three or more IPTp-SP doses was substantial at the community level [sigma(2) = 1. 86; Crl = 11.12-2.18] than regional level [sigma(2) = 1.13; Crl = 1.06-1.20]. About 18% and 47% disparity in IPTp-SP uptake are linked to region and community level factors respectively. Conclusion IPTp-SP interventions need to reflect broader community and region level factors in order to wane the high malaria prevalence in Uganda. Contextually responsive behavioural change communication interventions are required to invoke women's passion to achieve the recommended dosage.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study
    Steven Chifundo Azizi
    Gershom Chongwe
    Helen Chipukuma
    Choolwe Jacobs
    Jessy Zgambo
    Charles Michelo
    BMC Pregnancy and Childbirth, 18
  • [42] The Effectiveness of the Revised Intermittent Preventive Treatment with Sulphadoxine Pyrimethamine (IPTp-SP) in the Prevention of Malaria among Pregnant Women in Northern Ghana
    Agyeman, Yaa Nyarko
    Newton, Sam Kofi
    Annor, Raymond Boadu
    Owusu-Dabo, Ellis
    JOURNAL OF TROPICAL MEDICINE, 2020, 2020
  • [43] Defending the Use of Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment for Malaria in Pregnancy: A Short-Sighted Strategy Reply
    Gutman, Julie
    Taylor, Steve
    Meshnick, Steven R.
    ter Kuile, Feiko O.
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (03): : 497 - 498
  • [44] Predictors for uptake of intermittent preventive treatment of malaria in pregnancy (IPTp) in Tanzania
    Stephen M. Kibusi
    Eunice Kimunai
    Courtney S. Hines
    BMC Public Health, 15
  • [45] Protective Efficacy of Intermittent Preventive Treatment of Malaria in Infants (IPTi) Using Sulfadoxine-Pyrimethamine and Parasite Resistance
    Griffin, Jamie T.
    Cairns, Matthew
    Ghani, Azra C.
    Roper, Cally
    Schellenberg, David
    Carneiro, Ilona
    Newman, Robert D.
    Grobusch, Martin P.
    Greenwood, Brian
    Chandramohan, Daniel
    Gosling, Roly D.
    PLOS ONE, 2010, 5 (09): : 1 - 11
  • [46] Predictors for uptake of intermittent preventive treatment of malaria in pregnancy (IPTp) in Tanzania
    Kibusi, Stephen M.
    Kimunai, Eunice
    Hines, Courtney S.
    BMC PUBLIC HEALTH, 2015, 15
  • [47] Efficacy of intermittent treatment with sulfadoxine-pyrimethamine alone or sulfadoxine-pyrimethamine plus artesunate for prevention of placental malaria in Tanzania
    MacArthur, John R.
    Kabanywanyi, Abdunoor M.
    Baja, Abdullah
    Juma, Vera
    Maswi, Charles
    Bloland, Peter B.
    Kachur, S. Patrick
    Abdulla, Salim
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (05): : 238 - 238
  • [48] Uptake of four or more doses of sulfadoxine pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Zambia: findings from the 2018 malaria in pregnancy survey
    Sinyange, Danny
    Mukumbuta, Nawa
    Mutale, Lwito Salifya
    Mumbole, Hudson
    Hamainza, Busiku
    Sialubanje, Cephas
    BMJ OPEN, 2023, 13 (05):
  • [49] Safety and toxicity of sulfadoxine/pyrimethamine - Implications for malaria prevention in pregnancy using intermittent preventive treatment
    Peters, Philip J.
    Thigpen, Michael C.
    Parise, Monica E.
    Newman, Robert D.
    DRUG SAFETY, 2007, 30 (06) : 481 - 501
  • [50] Prevalence of Plasmodium falciparum Resistance Markers to Sulfadoxine-Pyrimethamine among Pregnant Women Receiving Intermittent Preventive Treatment for Malaria in Uganda
    Mbonye, Anthony K.
    Birungi, Josephine
    Yanow, Stephanie K.
    Shokoples, Sandra
    Malamba, Samuel
    Alifrangis, Michael
    Magnussen, Pascal
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (09) : 5475 - 5482